Literature DB >> 22249527

Antiplatelet therapy and proton pump inhibition: clinician update.

George V Moukarbel1, Deepak L Bhatt.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22249527     DOI： 10.1161/CIRCULATIONAHA.111.019745

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  6 in total

1.  The effects of proton pump inhibition on patient-reported severity of dyspepsia when receiving dual anti-platelet therapy with clopidogrel and low-dose aspirin: analysis from the Clopidogrel and the Optimization of Gastrointestinal Events Trial.

Authors:  M Vardi; B L Cryer; M Cohen; A Lanas; T J Schnitzer; P Lapuerta; M A Goldsmith; L Laine; G Doros; Y Liu; A I McIntosh; C P Cannon; D L Bhatt
Journal:  Aliment Pharmacol Ther       Date:  2015-05-29       Impact factor: 8.171

Review 2.  Post-PCI Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation.

Authors:  Mahesh V Madhavan; Ajay J Kirtane
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

3.  Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.

Authors:  Yen-Feng Wang; Yung-Tai Chen; Jiing-Chyuan Luo; Tzeng-Ji Chen; Jaw-Ching Wu; Shuu-Jiun Wang
Journal:  Am J Gastroenterol       Date:  2017-04-11       Impact factor: 10.864

4.  Proton pump inhibitor in the prevention of upper gastrointestinal mucosal injury associated with dual antiplatelet therapy after coronary artery bypass grafting (DACAB-GI-2): study protocol for a randomized controlled trial.

Authors:  Yunpeng Zhu; Xiaojin Wang; Yi Yang; Lei Liu; Qiang Zhao; Lifen Yu
Journal:  Trials       Date:  2022-07-15       Impact factor: 2.728

5.  Long term risk and costs of bleeding in men and women treated with triple antithrombotic therapy-An observational study.

Authors:  Anna Holm; Martin Henriksson; Joakim Alfredsson; Magnus Janzon; Therese Johansson; Eva Swahn; Dominique Vial; Sofia Sederholm Lawesson
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

6.  Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations.

Authors:  Adrian Covic; Simonetta Genovesi; Patrick Rossignol; Philip A Kalra; Alberto Ortiz; Maciej Banach; Alexandru Burlacu
Journal:  BMC Med       Date:  2018-09-19       Impact factor: 8.775
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.